SQZ Biotechnologies Company (SQZB)
OTCMKTS: SQZB · Delayed Price · USD
0.0370
0.00 (0.00%)
Jul 19, 2024, 2:51 PM EDT - Market closed

SQZB Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Net Income
-76.11-79.46-68.74-50.52-32.2-20.23
Depreciation & Amortization
11.9811.6811.0310.944.361.07
Share-Based Compensation
7.158.48.513.62.110.59
Other Operating Activities
-29.91-24.17-32.93-7.18-7.7538.69
Operating Cash Flow
-86.89-83.55-82.14-43.15-33.4921.1
Capital Expenditures
-0.36-0.49-0.61-1.18-2.17-1.31
Change in Investments
00059-10.68-35.66
Investing Cash Flow
-0.36-0.49-0.6157.82-12.85-36.96
Share Issuance / Repurchase
4.24.2357.8174.410.090.09
Other Financing Activities
---1.94225.9568.03
Financing Cash Flow
4.24.2355.91116.4226.0468.12
Net Cash Flow
-83.04-79.8-26.84131.09-20.352.26
Free Cash Flow
-87.25-84.04-82.75-44.33-35.6619.79
Free Cash Flow Margin
-468.81%-391.27%-305.37%-211.11%-177.33%156.22%
Free Cash Flow Per Share
-2.96-2.92-3.00-8.21-20.9212.47
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).